Maccura Biotechnology Co Ltd
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such a… Read more
Market Cap & Net Worth: Maccura Biotechnology Co Ltd (300463)
Maccura Biotechnology Co Ltd (SHE:300463) has a market capitalization of $951.02 Million (CN¥6.98 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #9548 globally and #1989 in its home market, demonstrating a 0.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Maccura Biotechnology Co Ltd's stock price CN¥11.54 by its total outstanding shares 604666624 (604.67 Million).
Maccura Biotechnology Co Ltd Market Cap History: 2015 to 2026
Maccura Biotechnology Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.95 Billion to $951.02 Million (-7.64% CAGR).
Maccura Biotechnology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Maccura Biotechnology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.43x
Maccura Biotechnology Co Ltd's market cap is 0.43 times its annual revenue
0.68x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
8.58x
Maccura Biotechnology Co Ltd's market cap is 8.58 times its annual earnings
359.02x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.95 Billion | $1.07 Billion | $251.04 Million | 2.77x | 11.74x |
| 2016 | $1.86 Billion | $1.49 Billion | $312.02 Million | 1.25x | 5.95x |
| 2017 | $1.82 Billion | $1.97 Billion | $374.13 Million | 0.92x | 4.86x |
| 2018 | $1.11 Billion | $2.69 Billion | $444.93 Million | 0.41x | 2.50x |
| 2019 | $2.07 Billion | $3.22 Billion | $525.26 Million | 0.64x | 3.94x |
| 2020 | $3.59 Billion | $3.70 Billion | $793.92 Million | 0.97x | 4.52x |
| 2021 | $2.27 Billion | $3.98 Billion | $956.60 Million | 0.57x | 2.37x |
| 2022 | $1.38 Billion | $3.61 Billion | $708.18 Million | 0.38x | 1.95x |
| 2023 | $1.23 Billion | $2.90 Billion | $312.62 Million | 0.42x | 3.92x |
| 2024 | $1.09 Billion | $2.55 Billion | $126.81 Million | 0.43x | 8.58x |
Competitor Companies of 300463 by Market Capitalization
Companies near Maccura Biotechnology Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Maccura Biotechnology Co Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Maccura Biotechnology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Maccura Biotechnology Co Ltd's market cap moved from $2.95 Billion to $ 951.02 Million, with a yearly change of -7.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥951.02 Million | +3.13% |
| 2025 | CN¥922.17 Million | -15.23% |
| 2024 | CN¥1.09 Billion | -11.21% |
| 2023 | CN¥1.23 Billion | -11.10% |
| 2022 | CN¥1.38 Billion | -39.24% |
| 2021 | CN¥2.27 Billion | -36.78% |
| 2020 | CN¥3.59 Billion | +73.34% |
| 2019 | CN¥2.07 Billion | +85.87% |
| 2018 | CN¥1.11 Billion | -38.78% |
| 2017 | CN¥1.82 Billion | -1.93% |
| 2016 | CN¥1.86 Billion | -37.07% |
| 2015 | CN¥2.95 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Maccura Biotechnology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $951.02 Million USD |
| MoneyControl | $951.02 Million USD |
| MarketWatch | $951.02 Million USD |
| marketcap.company | $951.02 Million USD |
| Reuters | $951.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.